Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality

Critical Care Medicine

Volumn 31, Issue 6, 2003, Pages 1808-1818

  Williams, David L ^a   Ha, Tuanzhu ^a   Li, Chuanfu ^a   Kalbfleisch, John H ^a   Schweitzer, John ^a   Vogt, William ^a   Browder, I William ^a  

^a East Tennessee State University   (United States)

Author keywords

Cecal ligation and puncture; Sepsis; Toll like receptor

Indexed keywords

GLUCAN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOPROPHYLAXIS; LIVER; LUNG; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SEPSIS; SPLEEN; SURVIVAL; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; ANALYSIS OF VARIANCE; ANIMALS; BETA-GLUCANS; GENE EXPRESSION REGULATION; GLUCANS; LIVER; LUNG; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED ICR; PROPORTIONAL HAZARDS MODELS; RANDOM ALLOCATION; RECEPTORS, CELL SURFACE; RNA, MESSENGER; SEPSIS; SURVIVAL ANALYSIS; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 0038047587     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000069343.27691.F3     Document Type: Article

References (37)

1. Muckart DJJ, Bhagwanjee S: American College of Chest Physicians Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit Care Med 1997; 25:1789-1795
2. Martin C, Boisson C, Haccoun M, et al: Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 1997; 25:1813-1819
3. Qureshi ST, Gros P, Halo D: Host resistance to infection: Genetic control of lipopolysaccharide responsiveness by Toll-like receptor genes. Trends Genet 1999; 15:291-294
4. Medzhitov R, Janeway CA: An ancient system of host defense. Curr Opin Immunol 2000; 10:12-15
5. Medzhitov R, Janeway CA: Self-defense: The fruit fly style. Proc Natl Acad Sci USA 1998; 95:429-430
6. Kopp EB, Medzhitov R: The Toll-receptor family and control of innate immunity. Curr Opin Immunol 1999; 11:13-18
7. Yoshimura A, Lien E, Ingalls RR, et al: Cutting edge; Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 1999; 163:1-5
8. Ulevitch RJ, Tobias PS: Recognition of Gramnegative bacteria and endotoxin by the innate immune system. Curr Opin Immunol 1999; 11:19-22
9. Ulevitch RJ: Endotoxin opens the Tollgates to innate immunity. Nat Med 1999; 5:144-145
10. Cario CE, Rosenberg IM, Brandwein SL, et al: Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 2000; 164:966-972
11. Modlin RL, Brightbill HD, Godowski PJ: The Toll of innate immunity on microbial pathogens. New Engl J Med 2000; 340:1834-1835
12. Kawai T, Adachi O, Ogawa T, et al: Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999; 11:115-122
13. Swantek JL, Tsen MF, Cob MH, et al: IL-1 receptor-associated kinase modulates host responsiveness to endotoxin. J Immunol 2000; 164:4301-4306
14. Takeuchi O, Hoshino K, Akira S: Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000; 165:5392-5396
15. Chow JC, Young DW, Golenbock DT, et al: Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999; 274:10689-10692
16. Lien E, Means TK, Heine H, et al: Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 2000; 105:497-504
17. Williams DL, Ha T, Li C, et al: Inhibiting early activation of tissue nuclear factor-kB and nuclear factor interleukin 6 with (1→3)-β-D-glucan increases long-term survival in polymicrobial sepsis. Surgery 1999; 126:54-65
18. Williams DL, Ha T, Li C, et al: Early activation of hepatic NPkB and NP-IL6 in polymicrobial sepsis correlates with bacteremia, cytokine expression and mortality. Ann Surg 1999; 230:95-104
19. Browder W, Ha T, Li C, et al: Early activation of pulmonary nuclear factor kB and nuclear factor interleukin-6 in polymicrobial sepsis. J Trauma 1999; 46:590-596
20. Williams DL, McNamee RB, Jones EL, et al: A method for the solubilization of a (1-3)-β-D-glucan isolated from Saccharomyces cerevisiae. Carbohydr Res 1991; 219:203-213
21. Pretus HA, Ensley HE, McNamee RB, et al: Isolation, physicochemical characterization and preclinical efficacy evaluation of soluble scleroglucan. J Pharmacol Exp Ther 1991; 257:500-510
22. Mueller A, Pretus H, McNamee R, et al: Comparison of the carbohydrate biological response modifiers Krestin, schizophyllan and glucan phosphate by aqueous size exclusion chromatography with in-line argon-ion multi-angle laser light scattering photometry and differential viscometry detectors. J Chromatogr 1995; 666;283-290
23. Lowman D, Ensley H, Williams D: Identification of phosphate substitution sites by NMR spectroscopy in a water-soluble phosphorylated (1-3)-β-D-glucan. Carbohydr Res 1998; 306:559-562
24. Williams DL, Mueller A, Browder W: Glucan-based macrophage stimulators: A review of their anti-infective potential. Clin Immunother 1996; 5:392-399
25. Williams DL, Ha T, Li C, et al: Inhibition of LPS induced NPκB activation by a glucan ligand involves down regulation of IKKβ kinase activity and altered phosphorylation and degradation of IκB. Shock 2000; 13:446-452
26. Frantz S, Kobzik L, Kim YD, et al; Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest 1999; 104:271-280
27. Muzio M, Natoli G, Saccani S, et al: The human Toll signaling pathway: Divergence of nuclear factor κB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med 1998; 187:2097-2101
28. Zhang G, Ghosh S: Toll-like receptor-mediated NF-kB activation: A phylogenetically conserved paradigm in innate immunity. J Clin Invest 2001; 107:13-19
29. Schwartz MD, Moore EE, Moore FA, et al: Nuclear factor-kappaB is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med 1996; 24:1285-1292
30. Böhrer H, Qiu F, Zimmermann T, et al: Role of NFκB in the mortality of sepsis. J Clin Invest 1997; 100:972-985
31. Musikacharoen T, Matsuguchi T, Kikuchi T, et al: NF-kappaB and stat5 play important roles in the regulation of mouse Toll-like receptor 2 gene expression. J Immunol 2001; 166:4516-4524
32. Schuster JM, Nelson PS: Toll receptors: An expanding role in our understanding of human disease. J Leukoc Biol 2000; 67:767-773
33. Cario E, Podolsky DK: Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000; 68:7010-7017
34. Backhed F, Soderhall M, Ekman P, et al: Induction of innate immune responses by Escherichia coli and purified lipopolysaccharide correlated with organ- and cell-specific expression of Toll-like receptors within the human urinary tract. Cell Microbiol 2001; 3:153-158
35. Liu Y, Wang Y, Yamakuchi M, et al: Upregulation of Toll-like receptor 2 gene expression in macrophage response to peptidoglycan and high concentration of lipopolysaccharide is involved in NF-kappa b activation. Infect Immun 2001; 69:2788-2796
36. Mueller A, Raptis J, Rice PJ, et al: The influence of glucan polymer structure and solution conformation on binding to (1→3)-β-D-glucan receptors in a human monocyte-like cell line. Glycobiology 2000; 10:339-346
37. Guha M, Mackman N; The PI3K-Akt pathway limits LPS activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 2002; 277:32124-32132